Technology
Health
Pharmaceutical

Aclaris Therapeutics

987

$1.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.66%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours

Why Robinhood?

You can buy or sell ACRS and other stocks, options, ETFs, and crypto commission-free!

About ACRS

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Dermatology Therapeutics and Contract Research segments. Read More The Dermatology Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

CEO
Neal S. Walker
Employees
169
Headquarters
Malvern, Pennsylvania
Founded
2012
Market Cap
73.67M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
743.79K
High Today
$1.80
Low Today
$1.72
Open Price
$1.77
Volume
289.87K
52 Week High
$9.75
52 Week Low
$0.74

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Biopharmaceutical
2015 IPO
US

ACRS News

ReutersNov 8

Edited Transcript of ACRS earnings conference call or presentation 7-Nov-19 10:00pm GMT

Q3 2019 Aclaris Therapeutics Inc Earnings Call MALVERN Nov 8, 2019 (Thomson StreetEvents) -- Edited Transcript of Aclaris Therapeutics Inc earnings conference
2

ACRS Earnings

-$1.33
-$1.07
-$0.82
-$0.56
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
-$0.57 per share
Actual
-$0.56 per share
Replay Earnings Call

You May Also Like

PNR
CHAP
SHYL
DVYA
THGA
SBS
APLT
VSAT
PSA-H
ABEV
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ACRS

Market Price$1.78
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ACRS stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up